You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in Singapore.
Any and all information provided is intended for general overview. Viewers taking any decision based on the information provided herein are requested to seek professional advice.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Bladder control problems affect millions of people. But relief is closer than you think.
See the stepsSpeak with a doctor in your community who can help you find the right treatment.
FIND A SPECIALISTTalking about your symptoms can be challenging. Our doctor discussion guide makes it easier.
DOWNLOAD THE GUIDE(opens new window)Connect with people who have experienced life-changing relief with Medtronic bladder control therapy.
Request a call(opens new window)See how others have reduced their symptoms and gotten their lives back.
READ THEIR STORIESIn addition to risks related to surgery, complications can include pain at the implant sites, new pain, infection, lead (thin wire) movement/ migration, device problems, undesirable changes in urinary or bowel function, and uncomfortable stimulation (sometimes described as a jolting or shocking feeling). Talk with your doctor about ways to minimize these risks.
Most common side effects of PTNM are temporary and include mild pain or skin inflammation at or near the stimulation site.
Under certain conditions; see approved labeling for details.
Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim® Therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34:224–230.
Peters, K. M., S. A. Macdiarmid, et al. (2009). "Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial." J Urol 182(3): 1055-1061.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.